Philanthropia

The giving app that gives back

My Philanthropia

Give

  • Charities
    • Charities By City
    • Charities By SDGs
  • Public Portfolios

Philanthropia

Philanthropia

Philanthropia

Give

  • Charities
    • Charities By City
    • Charities By SDGs
  • Public Portfolios
    Scleroderma Research Foundation Logo

    MIP Score

    69

    Med Research
    Lung Disease Research

    Scleroderma Research Foundation

    Scleroderma Research Foundation Logo

    Scleroderma Research Foundation

    Med Research
    Lung Disease Research
    220 Montgomery St, Ste 484, San Francisco, California, 94104View all San Francisco charities
    EIN: 68-0087234
    Total Assets: $11.14 million
    Established in 1987

    Mission

    The Scleroderma Research Foundation is the largest nonprofit investor in scleroderma research in the United States, focused on finding a cure for this rare autoimmune disease. The foundation promotes collaboration among leading scientists and medical institutions to advance innovative therapies.

    Read more on their website →

    Basic Information

    Tax-Exempt

    Address

    220 Montgomery St, Ste 484, San Francisco, California, 94104

    View all San Francisco charities

    Founded in

    1987

    EIN

    68-0087234

    Total Assets

    $11.14 million

    Mission

    The Scleroderma Research Foundation is the largest nonprofit investor in scleroderma research in the United States, focused on finding a cure for this rare autoimmune disease. The foundation promotes collaboration among leading scientists and medical institutions to advance innovative therapies.

    Basic Information

    Tax-Exempt

    Address

    220 Montgomery St, Ste 484, San Francisco, California, 94104

    View all San Francisco charities

    Founded in

    1987

    EIN

    68-0087234

    Total Assets

    $11.14 million

    UN Sustainable Development Goals Supported

    This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.

    Showing 3 of 3 goals

    Goal 3

    Good Health

    Goal 10

    Reduced Inequalities

    Goal 17

    Partnerships for the Goals

    Goal 3

    Good Health

    Goal 10

    Reduced Inequalities

    Goal 17

    Partnerships for the Goals

    At a Glance

    Cool Comedy • Hot Cuisine

    Cool Comedy • Hot Cuisine

    This annual comedy event raises funds for scleroderma research and also honors influential figures in the entertainment industry.

    Participate in Scleroderma Research

    Participate in Scleroderma Research

    Individuals can help advance research for scleroderma by participating in clinical studies.

    Annual Report 2023

    Annual Report 2023

    A comprehensive overview of the foundation's activities, financial highlights, and impact stories.

    Impact Stats

    1,000

    Number of Patients Enrolled

    1,000th Patient Enrolled in CONQUER

    Major milestone for the nation's only longitudinal scleroderma patient registry.

    $1.2 Million

    Total Funds Raised

    $1.2 Million Raised for Research (2024)

    Funds raised from the 'Cool Comedy • Hot Cuisine' event supporting scleroderma research.

    $40 Million

    Total Funding Committed

    Over $40 Million Committed to Research

    Financial commitment to advancing scleroderma research projects.

    Past Events

    Cool Comedy • Hot Cuisine 2023

    November 8, 2023

    Cool Comedy • Hot Cuisine 2023 raised significant funds to support research.

    Upcoming Events

    Cool Comedy • Hot Cuisine 2024

    Cool Comedy • Hot Cuisine 2024

    October 29, 2024

    Join us for a night of laughter and support for scleroderma research.

    Learn More

    Our Programs

    CONQUER Registry

    CONQUER Registry

    The first nationwide longitudinal registry for scleroderma patients.

    Learn More
    GRASP Project

    GRASP Project

    Research project focusing on health disparities affecting African American scleroderma patients.

    Learn More
    CONQUEST

    CONQUEST

    An innovative clinical trial platform for multiple manifestations of scleroderma.

    Learn More

    Volunteer Opportunities

    Volunteer with The Cure Crew

    Volunteer with The Cure Crew

    Join dedicated volunteers to raise awareness and funds for scleroderma research.

    Learn More

    Impact Reports

    PDF Icon

    Scleroderma Research Foundation Annual Report 2023

    MIP Score (Beta)

    The MIP Score is in beta! We'd love any feedback you may have.

    The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.

    Overall Score

    69

    58

    /100

    Program Expense Ratio

    80.28%

    12

    /20

    Program Revenue Growth

    1.04K%

    2

    /20

    Leverage Ratio

    0.1114

    18

    /20

    Working Capital Ratio

    2.126

    14

    /20

    Fundraising Efficiency

    1.389

    12

    /20

    Latest Filing Data: Form 990

    Fiscal Year:2022

    Source:Source: Self-reported by organization

    Financial Details

    Revenue

    CategoryAmountPercentage
    Contributions, Gifts, and Grants5.377M91.24%
    Program Services170.5K2.89%
    Investment Income116.8K1.98%
    Sales of Non-Inventory Assets00.00%
    Other Notable Sources16.53K0.28%
    Total Revenue5.893M100.00%

    Related Nonprofits

    Addario Lung Cancer Medical Institute

    Addario Lung Cancer Medical Institute

    Med Research

    Lung Disease Research
    Connecticut United for Research Excellence Inc.

    Connecticut United for Research Excellence Inc.

    Med Research

    Lung Disease Research
    Peter and Tommy Fund Inc. C/O Gary L Mucci

    Peter and Tommy Fund Inc. C/O Gary L Mucci

    Med Research

    Lung Disease Research
    Noah Worcester Dermatological Society Inc.

    Noah Worcester Dermatological Society Inc.

    Med Research

    Lung Disease Research
    Ride Hard Breathe Easy

    Ride Hard Breathe Easy

    Med Research

    Lung Disease Research

    Connect